in addition to increased insulin receptors in monocytes and fibroblasts , the present findings , plus similar findings with the oral hypoglycemic agent glibenclamide , may help explain the mechanism of the extra-pancreatic effects of oral sulfonylurea agents at the cellular level .
C0016030
fibroblasts
C0007634
cellular